Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
June 30, 2026 62.91%
March 31, 2026 64.24%
December 31, 2025 56.23%
September 30, 2025 62.70%
June 30, 2025 63.08%
March 31, 2025 62.29%
December 31, 2024 62.34%
September 30, 2024 64.58%
June 30, 2024 60.69%
March 31, 2024 61.90%
December 31, 2023 63.78%
September 30, 2023 60.83%
June 30, 2023 63.24%
March 31, 2023 64.10%
December 31, 2022 63.13%
September 30, 2022 61.88%
June 30, 2022 63.22%
March 31, 2022 61.76%
December 31, 2021 62.32%
September 30, 2021 63.09%
June 30, 2021 64.47%
March 31, 2021 64.34%
December 31, 2020 61.35%
September 30, 2020 62.28%
June 30, 2020 52.10%
Date Value
March 31, 2020 63.54%
December 31, 2019 65.08%
September 30, 2019 63.35%
June 30, 2019 63.01%
March 31, 2019 64.36%
December 31, 2018 64.67%
September 30, 2018 63.43%
June 30, 2018 64.00%
March 31, 2018 64.54%
December 31, 2017 64.42%
September 30, 2017 64.33%
June 30, 2017 65.05%
March 31, 2017 65.73%
December 31, 2016 61.88%
September 30, 2016 63.90%
June 30, 2016 58.62%
March 31, 2016 58.02%
December 31, 2015 55.46%
September 30, 2015 59.98%
June 30, 2015 69.46%
March 31, 2015 71.16%
December 31, 2014 72.52%
September 30, 2014 71.37%
June 30, 2014 71.43%
March 31, 2014 73.49%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Intuitive Surgical, Inc. 67.76%
Stryker Corp. 66.14%
Globus Medical, Inc. 65.92%
Johnson & Johnson 68.73%
Solventum Corp. 58.44%